Nevada Secretary of State amending its articles of incorporation to reflect the change in corporate name to “Modern Mobility Aids Inc.”. The Company’s current status with the state of Nevada is active.
The Company has incorporated two wholly owned subsidiary companies: Modern Mobility Aids, Inc., an Ontario, Canada, based company on September 9, 2009 and MDRM Group (Canada) Ltd. an Ontario, Canada based company on July 14, 2011. References in this report to “Modern Mobility Aids” refer to Galileo Life Sciences, Inc. and its two subsidiary companies, on a consolidated basis, unless otherwise indicated or the context otherwise requires.
Has the Company’s or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes: ? No: ?
If the Company’s or any of its predecessors have been the subject of such proceedings, please provide additional
details in the space below:
Not Applicable.
2. SecurityInformation
The Issuer trades on the pink sheets maintained by OTC Markets Group, Inc. The exact title and class of securities outstanding.
Trading symbol:
Exact title and class of securities outstanding: CUSIP:
Par or stated value:
Total shares authorized:
Total shares outstanding:
Number of shares in the Public Float2:
Total number of shareholders of record:
MDRM
Common Stock 607674108 $0.001
1,000,000,000 189,046,153 67,813,333
90
as of date: December 15, 2020 as of date: December 15, 2020 as of date: December 15, 2020
as of date: December 15, 2020
as of date: Not Applicable as of date: Not Applicable
All additional class(es) of publicly traded securities (if any):
Trading symbol:
Exact title and class of securities outstanding: CUSIP:
Par or stated value:
Total shares authorized:
Total shares outstanding:
The Transfer Agent:
Vstock Transfer, LLC
18 Lafayette Place Woodmere, NY 11598 (212) 828-8436 www.vstocktransfer.com
Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable
2 “Public Float” shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a “control person”), or any affiliates thereof, or any im
